Proton Therapy Bridges the Silk Road of Health - Guangzhou Concord Cancer Center and Medical Peers from Russia and Kazakhstan Discuss Collaborative Oncology Care
In April, with spring in full bloom in Guangzhou, against the backdrop of deepening convergence between the "Health Silk Road" initiative and the development of the Guangdong-Hong Kong-Macao Greater Bay Area, Guangzhou Concord Cancer Center (hereinafter referred to as "GCCC") has ushered in another significant moment for deepening international medical cooperation.
On April 1, organized by the international medical referral agency Asian Healthcare Solution (Fengsheng Xuxu, hereinafter referred to as "AHS"), representatives from 10 medical referral institutions and oncology specialists from countries including Russia and Kazakhstan visited GCCC. President of Guangzhou Concord Cancer Center, Qian Chaonan, Assistant to the President of Concord Healthcare Group, Huang Chen, and Deputy Director of the Business Development Department of Guangzhou Concord Cancer Center, You Jin, along with other hospital representatives, had in-depth exchanges with the visiting guests.
Vascular surgeon Aleksei Di, radiation therapist Denis Romanov, and several other oncology specialists also joined the visit. The purpose of this trip was to gain an in-depth understanding of the hospital's expertise and clinical practices in precision oncology, particularly in the field of proton therapy, and to jointly explore viable models for international patient referral and medical technology collaboration.
The delegation tours the hospital's radiotherapy center and proton therapy equipment.
That morning, accompanied by President Qian Chaonan, the visiting delegation toured the hospital’s core facilities, conducting on-site inspections of the complete patient care workflow, the radiotherapy center, the proton therapy center, and the VIP inpatient ward.
At the radiotherapy center, the visiting group gained a thorough understanding of the comprehensive system spanning from initial patient consultation and multidisciplinary team (MDT) discussion to the formulation of individualized treatment plans. The hospital's internationally oriented care environment, multilingual service capabilities, and consistent patient-centered approach left a lasting impression on the guests. In front of the first proton therapy system in South China, the delegation members paused with keen interest , expressing strong interest in the system's precision, treatment efficiency, and clinical outcomes.
The delegation tours the hospital's radiotherapy center and proton therapy equipment
Following the on-site tour, both parties engaged in focused thematic presentations and discussions on the clinical application of proton therapy, supported by real-world case studies.
Drawing on multiple successful cases, President Qian Chaonan provided a detailed explanation of the distinctive physical properties of proton therapy — namely, precise tumor targeting with maximal sparing of surrounding healthy tissues. He further outlined the complete clinical pathway of the "Concord Protocol," from treatment plan formulation and personalized design guided by multimodal imaging, to efficacy monitoring and prognostic management throughout the course of treatment. The compelling clinical data and in-depth case presentations provided the visiting delegation with a more direct and profound appreciation of the clinical value of proton therapy.
The delegation tours the hospital's radiotherapy center and proton therapy equipment
During the open discussion that followed, members of the visiting delegation engaged in in-depth conversations with hospital representatives on specific topics including international patient referral procedures, telemedicine consultation mechanisms, direct insurance billing arrangements, and postoperative rehabilitation support.
In her remarks, Ms. Oksana Goncharuk stated: "The proton therapy capabilities at GCCC are impressive, and what resonates with us even more is the hospital's 'patient-centered' service philosophy. From precision treatment planning to attentive, compassionate care, this institution truly embodies both clinical excellence and warmth." She also expressed her anticipation for deeper collaboration and offered specific recommendations for serving Russian-speaking patients: "Patients from Russia and Kazakhstan place great importance on the accuracy of medical document translation. We hope that in the future, seamless integration can be achieved in areas such as Russian-language medical reports and linguistic support, enabling more patients from Russian-speaking regions to confidently choose to seek treatment here."
In response to the suggestions raised by the visiting guests, Huang Chen, Assistant to the President of Concord Healthcare Group, provided a positive and prompt response. He stated: "The hospital places great importance on this collaboration. Regarding requirements such as Russian-language case reports, we can confirm that this is fully achievable. GCCC possesses the comprehensive capabilities required to serve patients from Russia and other Russian-speaking regions, encompassing the full spectrum of services including dedicated interpreters, multilingual medical services, and the provision of Russian-language medical reports. We are committed to delivering professional, meticulous, and efficient services to ensure that every international patient enjoys a reassuring healthcare experience."
President Qian Chaonan presents proton therapy case studies at the symposium.
In his closing remarks, President Qian Chaonan stated: "Healthcare transcends borders; together, we look to the future. GCCC has always upheld an open and collaborative stance, and stands ready to establish sustained partnership mechanisms with medical institutions and referral networks worldwide, extending high-quality healthcare to a broader patient population. This exchange represents not only the sharing of expertise, but also the building of mutual trust. With professionalism as our foundation and service as our bridge, we look forward to joining hands with all partners to contribute to the advancement of the 'Health Silk Road.'"
The visiting delegation poses for a group photo in the hospital lobby
This visit and exchange not only provided medical professionals from Russia, Kazakhstan, and other countries with a comprehensive understanding of the clinical expertise and service philosophy of GCCC, but also laid a solid foundation for future substantive international patient referral collaboration. Leveraging the policy and geographic advantages of the Guangdong-Hong Kong-Macao Greater Bay Area, GCCC is steadily evolving into a vital platform for healthcare cooperation between China and countries along the "Belt and Road."